Related Articles
Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome
Ghrelin in patients with irritable bowel syndrome
Stomach antral endocrine cells in patients with irritable bowel syndrome
Reduced chromogranin A cell density in the ileum of patients with irritable bowel syndrome
Monocyte chemotactic protein‑1 and nitrotyrosine in irritable bowel syndrome